377 related articles for article (PubMed ID: 30617096)
21. Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii.
Park YK; Lee JY; Ko KS
Clin Microbiol Infect; 2015 Aug; 21(8):765.e1-7. PubMed ID: 25911992
[TBL] [Abstract][Full Text] [Related]
22. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.
Sun B; Liu H; Jiang Y; Shao L; Yang S; Chen D
mSphere; 2020 Apr; 5(2):. PubMed ID: 32238571
[TBL] [Abstract][Full Text] [Related]
23. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.
López-Rojas R; Domínguez-Herrera J; McConnell MJ; Docobo-Peréz F; Smani Y; Fernández-Reyes M; Rivas L; Pachón J
J Infect Dis; 2011 Feb; 203(4):545-8. PubMed ID: 21216865
[TBL] [Abstract][Full Text] [Related]
24. Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.
Wand ME; Bock LJ; Bonney LC; Sutton JM
J Antimicrob Chemother; 2015 Aug; 70(8):2209-16. PubMed ID: 25904728
[TBL] [Abstract][Full Text] [Related]
25. Analyzing pmrA and pmrB genes in Acinetobacter baumannii resistant to colistin in Shahid Rajai Shiraz, Iran Hospital by PCR: First report in Iran.
Sepahvand S; Doudi M; Davarpanah MA; Bahador A; Ahmadi M
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1401-6. PubMed ID: 27592491
[TBL] [Abstract][Full Text] [Related]
26. Genomic and phenotypic analyses of multidrug-resistant
Kim M; Park J; Park W
Virulence; 2021 Dec; 12(1):150-164. PubMed ID: 33372826
[TBL] [Abstract][Full Text] [Related]
27. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
[TBL] [Abstract][Full Text] [Related]
28. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM
Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125
[TBL] [Abstract][Full Text] [Related]
29.
Jones CL; Singh SS; Alamneh Y; Casella LG; Ernst RK; Lesho EP; Waterman PE; Zurawski DV
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993849
[TBL] [Abstract][Full Text] [Related]
30. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
Jaidane N; Naas T; Mansour W; Radhia BB; Jerbi S; Boujaafar N; Bouallegue O; Bonnin RA
Int J Antimicrob Agents; 2018 Feb; 51(2):266-269. PubMed ID: 29127051
[TBL] [Abstract][Full Text] [Related]
31.
Nodari CS; Fuchs SA; Xanthopoulou K; Cayô R; Seifert H; Gales AC; Dilthey A; Higgins PG
mSphere; 2021 Dec; 6(6):e0074621. PubMed ID: 34851165
[TBL] [Abstract][Full Text] [Related]
32. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.
Arroyo LA; Herrera CM; Fernandez L; Hankins JV; Trent MS; Hancock RE
Antimicrob Agents Chemother; 2011 Aug; 55(8):3743-51. PubMed ID: 21646482
[TBL] [Abstract][Full Text] [Related]
33. Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
Yoon EJ; Kim HS; Woo H; Choi YJ; Won D; Choi JR; Kim YA; Jeong SH
J Antimicrob Chemother; 2021 Dec; 77(1):69-73. PubMed ID: 34609499
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.
Savari M; Ekrami A; Shoja S; Bahador A
Folia Microbiol (Praha); 2017 Sep; 62(5):373-379. PubMed ID: 28238067
[TBL] [Abstract][Full Text] [Related]
35. The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii.
Seleim SM; Mostafa MS; Ouda NH; Shash RY
Sci Rep; 2022 Dec; 12(1):20951. PubMed ID: 36470921
[TBL] [Abstract][Full Text] [Related]
36. Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.
Pournaras S; Poulou A; Dafopoulou K; Chabane YN; Kristo I; Makris D; Hardouin J; Cosette P; Tsakris A; Dé E
Antimicrob Agents Chemother; 2014; 58(2):828-32. PubMed ID: 24247145
[TBL] [Abstract][Full Text] [Related]
37. Relationship Between Different Resistance Mechanisms and Virulence in
Espinal P; Pantel A; Rolo D; Marti S; López-Rojas R; Smani Y; Pachón J; Vila J; Lavigne JP
Microb Drug Resist; 2019 Jun; 25(5):752-760. PubMed ID: 30632884
[No Abstract] [Full Text] [Related]
38. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
40. A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii.
Chin CY; Gregg KA; Napier BA; Ernst RK; Weiss DS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7911-4. PubMed ID: 26459891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
